Concepts (182)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Retinoids | 7 | 2021 | 28 | 3.130 |
Why?
|
| Hypervitaminosis A | 4 | 2019 | 4 | 1.810 |
Why?
|
| Autistic Disorder | 3 | 2019 | 37 | 1.720 |
Why?
|
| Vitamin A | 8 | 2019 | 87 | 1.640 |
Why?
|
| Liver Diseases | 2 | 2021 | 31 | 1.510 |
Why?
|
| Rubella | 2 | 2019 | 13 | 1.430 |
Why?
|
| Burkitt Lymphoma | 2 | 2017 | 23 | 1.260 |
Why?
|
| Terrorism | 2 | 2023 | 12 | 1.230 |
Why?
|
| Disasters | 3 | 2023 | 64 | 1.210 |
Why?
|
| Malaria, Falciparum | 2 | 2017 | 81 | 0.990 |
Why?
|
| Herpesvirus 4, Human | 2 | 2017 | 33 | 0.790 |
Why?
|
| Epstein-Barr Virus Infections | 2 | 2017 | 15 | 0.780 |
Why?
|
| Aggression | 2 | 2013 | 75 | 0.770 |
Why?
|
| Liver | 4 | 2019 | 447 | 0.730 |
Why?
|
| Rubella Syndrome, Congenital | 1 | 2019 | 2 | 0.730 |
Why?
|
| Mumps | 1 | 2019 | 2 | 0.730 |
Why?
|
| Measles | 1 | 2019 | 6 | 0.730 |
Why?
|
| Sex Education | 1 | 2019 | 29 | 0.710 |
Why?
|
| Pregnancy in Adolescence | 1 | 2019 | 33 | 0.710 |
Why?
|
| Persian Gulf Syndrome | 1 | 2019 | 2 | 0.700 |
Why?
|
| School Health Services | 1 | 2019 | 77 | 0.670 |
Why?
|
| Humans | 29 | 2023 | 34853 | 0.610 |
Why?
|
| Stuttering | 1 | 2016 | 3 | 0.590 |
Why?
|
| Plasmodium falciparum | 2 | 2017 | 121 | 0.560 |
Why?
|
| Stevens-Johnson Syndrome | 1 | 2015 | 3 | 0.530 |
Why?
|
| Motor Vehicles | 1 | 2014 | 13 | 0.510 |
Why?
|
| Accidents, Traffic | 1 | 2014 | 42 | 0.500 |
Why?
|
| Leukocytes | 2 | 2011 | 68 | 0.500 |
Why?
|
| Automobile Driving | 1 | 2014 | 27 | 0.500 |
Why?
|
| Cholestasis, Intrahepatic | 1 | 2013 | 1 | 0.480 |
Why?
|
| Psychoses, Substance-Induced | 1 | 2013 | 2 | 0.480 |
Why?
|
| Mefloquine | 1 | 2013 | 3 | 0.480 |
Why?
|
| Depression, Postpartum | 1 | 2013 | 10 | 0.470 |
Why?
|
| Health Surveys | 1 | 2015 | 358 | 0.460 |
Why?
|
| Models, Biological | 2 | 2013 | 642 | 0.460 |
Why?
|
| Dengue Virus | 1 | 2013 | 84 | 0.440 |
Why?
|
| Erythrocytes | 1 | 2013 | 107 | 0.430 |
Why?
|
| Breast Feeding | 1 | 2013 | 105 | 0.430 |
Why?
|
| Wounds, Gunshot | 1 | 2011 | 26 | 0.390 |
Why?
|
| Atherosclerosis | 1 | 2011 | 131 | 0.370 |
Why?
|
| Brain Injuries | 1 | 2011 | 104 | 0.350 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2011 | 160 | 0.340 |
Why?
|
| Brain | 1 | 2016 | 1268 | 0.340 |
Why?
|
| Ascorbic Acid Deficiency | 1 | 2008 | 2 | 0.340 |
Why?
|
| Exanthema | 1 | 2008 | 9 | 0.340 |
Why?
|
| Bone Diseases | 1 | 2008 | 18 | 0.330 |
Why?
|
| Growth Disorders | 1 | 2008 | 22 | 0.330 |
Why?
|
| Respiratory Tract Infections | 1 | 2008 | 31 | 0.330 |
Why?
|
| Child | 5 | 2016 | 2875 | 0.310 |
Why?
|
| Heart Rate | 1 | 2008 | 248 | 0.300 |
Why?
|
| Vaccination | 2 | 2019 | 259 | 0.300 |
Why?
|
| Health Services Needs and Demand | 3 | 2019 | 143 | 0.290 |
Why?
|
| Pregnancy | 4 | 2019 | 1503 | 0.280 |
Why?
|
| Child, Preschool | 3 | 2016 | 1318 | 0.280 |
Why?
|
| Pain | 1 | 2008 | 249 | 0.270 |
Why?
|
| Mass Behavior | 1 | 2005 | 2 | 0.260 |
Why?
|
| Malaria | 2 | 2017 | 68 | 0.260 |
Why?
|
| Panic Disorder | 1 | 2005 | 94 | 0.240 |
Why?
|
| Female | 9 | 2019 | 19873 | 0.240 |
Why?
|
| Social Behavior | 1 | 2005 | 124 | 0.240 |
Why?
|
| Risk Factors | 3 | 2019 | 3414 | 0.230 |
Why?
|
| Onchocerciasis | 1 | 2002 | 6 | 0.220 |
Why?
|
| Total Quality Management | 1 | 2002 | 9 | 0.220 |
Why?
|
| Violence | 1 | 2023 | 126 | 0.220 |
Why?
|
| Cesarean Section | 1 | 2002 | 53 | 0.220 |
Why?
|
| Managed Care Programs | 1 | 2002 | 35 | 0.220 |
Why?
|
| Evidence-Based Medicine | 1 | 2002 | 92 | 0.220 |
Why?
|
| Pre-Eclampsia | 1 | 2003 | 57 | 0.210 |
Why?
|
| Epidemiology | 1 | 2002 | 6 | 0.210 |
Why?
|
| Fear | 1 | 2005 | 234 | 0.210 |
Why?
|
| Clinical Trials as Topic | 1 | 2003 | 195 | 0.210 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2003 | 219 | 0.210 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2003 | 99 | 0.200 |
Why?
|
| Mississippi | 2 | 2019 | 107 | 0.200 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2021 | 48 | 0.200 |
Why?
|
| Liver Cirrhosis | 1 | 2021 | 51 | 0.200 |
Why?
|
| Adolescent | 3 | 2019 | 5035 | 0.190 |
Why?
|
| Rubella virus | 1 | 2019 | 10 | 0.180 |
Why?
|
| Pyridostigmine Bromide | 1 | 2019 | 5 | 0.170 |
Why?
|
| Infant, Newborn | 2 | 2013 | 871 | 0.170 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2019 | 41 | 0.170 |
Why?
|
| Infant | 2 | 2013 | 1014 | 0.170 |
Why?
|
| Male | 6 | 2016 | 18870 | 0.160 |
Why?
|
| Veterans | 1 | 2019 | 115 | 0.160 |
Why?
|
| Blood Pressure | 2 | 2011 | 613 | 0.150 |
Why?
|
| HIV-1 | 1 | 2003 | 678 | 0.150 |
Why?
|
| Environmental Exposure | 1 | 2019 | 207 | 0.150 |
Why?
|
| B-Lymphocytes | 1 | 2017 | 181 | 0.140 |
Why?
|
| Cohort Studies | 1 | 2019 | 1422 | 0.130 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 2015 | 10 | 0.130 |
Why?
|
| Cholestasis | 1 | 2015 | 9 | 0.130 |
Why?
|
| India | 1 | 2015 | 82 | 0.130 |
Why?
|
| Epidermis | 1 | 2015 | 26 | 0.130 |
Why?
|
| Arabs | 2 | 2012 | 13 | 0.130 |
Why?
|
| Keratinocytes | 1 | 2015 | 65 | 0.130 |
Why?
|
| Safety | 1 | 2014 | 48 | 0.120 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2015 | 112 | 0.120 |
Why?
|
| Mastitis | 1 | 2013 | 2 | 0.120 |
Why?
|
| Skin | 1 | 2015 | 173 | 0.120 |
Why?
|
| Adult | 4 | 2013 | 11034 | 0.120 |
Why?
|
| Milk | 1 | 2013 | 48 | 0.120 |
Why?
|
| Antifungal Agents | 1 | 2015 | 147 | 0.120 |
Why?
|
| Rural Population | 1 | 2015 | 253 | 0.110 |
Why?
|
| Hemolysis | 1 | 2013 | 39 | 0.110 |
Why?
|
| Mother-Child Relations | 1 | 2013 | 55 | 0.110 |
Why?
|
| Oxidoreductases | 1 | 2013 | 82 | 0.110 |
Why?
|
| Hospitals, Public | 1 | 2012 | 12 | 0.110 |
Why?
|
| Anemia | 1 | 2013 | 45 | 0.110 |
Why?
|
| Hospital Costs | 1 | 2012 | 22 | 0.110 |
Why?
|
| Tretinoin | 1 | 2013 | 50 | 0.110 |
Why?
|
| Endocytosis | 1 | 2013 | 104 | 0.110 |
Why?
|
| Premature Birth | 1 | 2013 | 71 | 0.110 |
Why?
|
| Mice, Inbred BALB C | 1 | 2013 | 649 | 0.100 |
Why?
|
| Anti-Bacterial Agents | 1 | 2015 | 355 | 0.100 |
Why?
|
| Creatinine | 1 | 2011 | 101 | 0.100 |
Why?
|
| Aged | 3 | 2011 | 6448 | 0.100 |
Why?
|
| Glomerular Filtration Rate | 1 | 2011 | 137 | 0.100 |
Why?
|
| Israel | 1 | 2011 | 18 | 0.100 |
Why?
|
| Medical Record Linkage | 1 | 2011 | 15 | 0.100 |
Why?
|
| Lymphocytes | 1 | 2011 | 116 | 0.100 |
Why?
|
| Neutrophils | 1 | 2011 | 124 | 0.100 |
Why?
|
| Fellowships and Scholarships | 1 | 2010 | 26 | 0.100 |
Why?
|
| Career Choice | 1 | 2010 | 44 | 0.090 |
Why?
|
| Health Services Research | 1 | 2010 | 133 | 0.090 |
Why?
|
| Primary Health Care | 1 | 2012 | 283 | 0.090 |
Why?
|
| Animals | 3 | 2013 | 14307 | 0.090 |
Why?
|
| Monocytes | 1 | 2011 | 258 | 0.090 |
Why?
|
| HIV Infections | 1 | 2003 | 2207 | 0.090 |
Why?
|
| Mythology | 1 | 2008 | 2 | 0.090 |
Why?
|
| Social Alienation | 1 | 2008 | 4 | 0.090 |
Why?
|
| Relief Work | 1 | 2008 | 7 | 0.080 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 964 | 0.080 |
Why?
|
| Middle Aged | 3 | 2011 | 9642 | 0.080 |
Why?
|
| Terminology as Topic | 1 | 2008 | 32 | 0.080 |
Why?
|
| Incidence | 1 | 2011 | 882 | 0.080 |
Why?
|
| Retrospective Studies | 2 | 2012 | 1961 | 0.080 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2008 | 63 | 0.080 |
Why?
|
| Public Health | 2 | 2010 | 348 | 0.080 |
Why?
|
| Neural Pathways | 1 | 2008 | 120 | 0.080 |
Why?
|
| Vitamins | 1 | 2008 | 91 | 0.080 |
Why?
|
| Disaster Planning | 1 | 2008 | 51 | 0.080 |
Why?
|
| Apoptosis | 1 | 2015 | 1317 | 0.080 |
Why?
|
| Family | 1 | 2008 | 162 | 0.080 |
Why?
|
| Minority Groups | 1 | 2010 | 537 | 0.070 |
Why?
|
| Residence Characteristics | 1 | 2008 | 301 | 0.070 |
Why?
|
| Chronic Disease | 1 | 2008 | 469 | 0.070 |
Why?
|
| Psychology | 1 | 2005 | 32 | 0.060 |
Why?
|
| Terminally Ill | 1 | 2003 | 3 | 0.060 |
Why?
|
| Patents as Topic | 1 | 2003 | 11 | 0.060 |
Why?
|
| Sample Size | 1 | 2003 | 28 | 0.060 |
Why?
|
| Ivermectin | 1 | 2002 | 2 | 0.060 |
Why?
|
| Onchocerca volvulus | 1 | 2002 | 5 | 0.060 |
Why?
|
| Unnecessary Procedures | 1 | 2002 | 9 | 0.060 |
Why?
|
| Health Services Misuse | 1 | 2002 | 12 | 0.060 |
Why?
|
| Vaginal Birth after Cesarean | 1 | 2002 | 4 | 0.060 |
Why?
|
| Information Services | 1 | 2002 | 14 | 0.060 |
Why?
|
| Mice | 1 | 2013 | 5668 | 0.060 |
Why?
|
| Education, Medical, Continuing | 1 | 2002 | 31 | 0.050 |
Why?
|
| Anthelmintics | 1 | 2002 | 16 | 0.050 |
Why?
|
| Diet | 1 | 2008 | 747 | 0.050 |
Why?
|
| United States | 3 | 2010 | 3894 | 0.050 |
Why?
|
| Young Adult | 1 | 2011 | 4012 | 0.050 |
Why?
|
| Stress, Psychological | 1 | 2005 | 541 | 0.040 |
Why?
|
| Diastole | 1 | 2010 | 46 | 0.020 |
Why?
|
| Systole | 1 | 2010 | 65 | 0.020 |
Why?
|
| Mentors | 1 | 2010 | 111 | 0.020 |
Why?
|
| Peer Group | 1 | 2010 | 138 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2010 | 429 | 0.020 |
Why?
|
| Survival | 1 | 2008 | 8 | 0.020 |
Why?
|
| Foreign Medical Graduates | 1 | 2008 | 4 | 0.020 |
Why?
|
| Anxiety, Separation | 1 | 2008 | 4 | 0.020 |
Why?
|
| Louisiana | 1 | 2008 | 39 | 0.020 |
Why?
|
| Curriculum | 1 | 2010 | 237 | 0.020 |
Why?
|
| International Cooperation | 1 | 2008 | 44 | 0.020 |
Why?
|
| Water Supply | 1 | 2008 | 54 | 0.020 |
Why?
|
| Housing | 1 | 2008 | 54 | 0.020 |
Why?
|
| Texas | 1 | 2008 | 299 | 0.020 |
Why?
|
| Food Supply | 1 | 2008 | 99 | 0.020 |
Why?
|
| Vulnerable Populations | 1 | 2008 | 132 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2010 | 1353 | 0.020 |
Why?
|
| Healthcare Disparities | 1 | 2010 | 446 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2010 | 2561 | 0.010 |
Why?
|